Verrica Pharmaceuticals Inc
VRCA
Company Profile
Business description
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Contact
44 West Gay Street
Suite 400
West ChesterPA19380
USAT: +1 484 453-3300
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
71
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,820.30 | 6.40 | -0.07% |
| CAC 40 | 7,828.78 | 73.47 | -0.93% |
| DAX 40 | 24,265.12 | 191.69 | -0.78% |
| Dow JONES (US) | 44,416.92 | 233.72 | -0.52% |
| FTSE 100 | 8,940.91 | 34.75 | -0.39% |
| HKSE | 24,139.57 | 111.20 | 0.46% |
| NASDAQ | 20,625.93 | 4.74 | -0.02% |
| Nikkei 225 | 39,569.68 | 76.68 | -0.19% |
| NZX 50 Index | 12,686.68 | 73.52 | -0.58% |
| S&P 500 | 6,262.05 | 18.41 | -0.29% |
| S&P/ASX 200 | 8,580.10 | 9.10 | -0.11% |
| SSE Composite Index | 3,510.18 | 0.50 | 0.01% |